prolaio eVO2peak Module vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
prolaio eVO2peak Module
by Prolaio
VS
PMcardio
by Powerful Medical

AI Verdict

Prolaio's eVO2peak Module focuses on estimating peak oxygen consumption using real-world patient data from remote sensors for cardiovascular research and care. PMcardio, on the other hand, is an AI platform that interprets 12-lead ECGs to rapidly assess over 50 cardiac conditions and provide diagnostic reports and treatment recommendations. While both are cardiology AI tools, Prolaio emphasizes continuous monitoring and risk assessment for conditions like heart failure and HCM progression, whereas PMcardio specializes in immediate, expert-level ECG interpretation for a broad range of cardiac diagnoses at the point of care.

Choose prolaio eVO2peak Module if…

Choose Prolaio eVO2peak Module if you need to estimate peak oxygen consumption (eVO2peak) in adult patients using real-world data from FDA-cleared wearable sensors. This tool is ideal for cardiovascular research and clinical evaluation where an adjunctive aid for assessing cardiopulmonary functional capacity is desired, without requiring a formal cardiopulmonary exercise test (CPET).

View prolaio eVO2peak Module →

Choose PMcardio if…

Choose PMcardio if you require rapid and accurate AI-powered interpretation of ECGs for the assessment of over 50 cardiac conditions at the point of care. This tool is particularly well-suited for emergency medicine, general practice, and cardiology settings where quick detection of conditions like STEMI/OMI, arrhythmias, and reduced LVEF is critical for timely clinical decision-making and improved patient outcomes.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature prolaio eVO2peak Module PMcardio
Pricing Contact for pricing Freemium
Deployment Cloud-based (software-only, processes remote sensor data) Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers a mobile app and web platform, along with enterprise integrations, making it highly accessible for individual clinicians and organizations. Its freemium model allows users to experience the tool before committing, and reviews highlight its ease of use for rapid ECG interpretation.

Clinical Value

PMcardio

PMcardio has been clinically validated in over 25 studies, demonstrating superior accuracy in detecting over 50 cardiac conditions, including STEMI and reduced LVEF. Prolaio's eVO2peak Module, while FDA-cleared and clinically validated, focuses on a single metric (eVO2peak) as an adjunctive aid in clinical evaluation.

Pricing & Value

PMcardio

PMcardio offers a transparent freemium model with a free plan for limited use and clearly outlined paid plans for individuals, teams, and organizations. Prolaio's pricing is 'contact for pricing,' which offers less transparency for potential users.

Enterprise Readiness

PMcardio

PMcardio explicitly mentions enterprise integrations with EHR/CVIS and EMS systems, and offers 'PMcardio for Organizations' with custom pricing and unlimited users/locations. Prolaio's deployment is cloud-based and processes remote sensor data, implying enterprise capability, but lacks explicit details on integrations or organizational-specific offerings for its eVO2peak module.

Innovation

PMcardio

PMcardio features 'ECGxplainu2122' for visual AI explainability with heatmaps and 'Queen of Heartsu2122' for STEMI and OMI detection, showcasing advanced AI capabilities and transparency. Prolaio's innovation lies in its deep-learning model for eVO2peak estimation using real-world data from wearable sensors, which is valuable but less broadly applicable in terms of diagnostic scope.

Support & Docs

Tie

Both tools are FDA-cleared (Prolaio) or CE-certified (PMcardio) and HIPAA compliant, suggesting a commitment to regulatory standards that typically include robust documentation. However, specific details about the breadth and accessibility of their support and documentation are not extensively detailed in the provided information or readily available through general web searches for either product.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature prolaio eVO2peak Module PMcardio
Name prolaio eVO2peak Module PMcardio
Company Prolaio Powerful Medical
Tagline Heart care, connected. AI that reads ECGs in seconds
Key Functionality Estimates peak oxygen consumption (eVO2peak) using demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors. Interprets ECGs to assess over 50 cardiac conditions, including STEMI/OMI, rhythms, reduced LVEF, and conduction disorders, with instant AI-powered interpretations and visual AI explainability.
Specialties Cardiology, Physical Medicine & Rehab, Sports Medicine Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring prolaio eVO2peak Module and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Prolaio eVO2peak Module is a cloud-based software that processes data from remote sensors, suggesting integration would involve data transfer from third-party wearable devices and potentially into the EHR for adjunctive clinical evaluation. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, and its mobile app and web platform can seamlessly integrate into fast-paced clinical routines, supporting rapid diagnostic support and care coordination.
Prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) using demographic data, single-lead ECG, and triaxial accelerometry, providing adjunctive information for cardiovascular research and care. PMcardio interprets ECGs to assess over 50 cardiac conditions, including STEMI/OMI and reduced LVEF, with its AI models demonstrating 2x the diagnostic accuracy of traditional ECG interpretation tools and 98.3% accuracy for atrial fibrillation detection.
PMcardio is designed for frontline decision-makers across various specialties, suggesting an intuitive interface for rapid use in acute care settings. While specific details on the learning curve for Prolaio eVO2peak Module are not provided, its role as an adjunctive aid implies it would complement existing clinical evaluation processes. PMcardio offers email support and a help center for individual users, with more comprehensive support for teams and organizations.
PMcardio is GDPR and HIPAA compliant and adheres to SOC 2 and ISO 27001 certifications, with a Trust Center for detailed security protocols. For organizations, PMcardio also offers audit logs. Prolaio has secured ISO 13485:2016 and MDSAP certification, demonstrating a quality-first approach across design, manufacturing, and support, which implies robust security and quality management systems.
PMcardio for Organizations is a unified cardiac AI platform designed for system-wide deployment across multiple sites and pathways, enabling standardization of clinical decisions and providing visibility into performance and outcomes across all deployed suites. Prolaio's cloud-based nature and focus on high-density, longitudinal data collection could support multi-site research initiatives, but specific features for multi-site clinical rollout and standardization are not detailed.
Prolaio eVO2peak Module is intended for estimating peak oxygen consumption in adult patients for cardiovascular research and care, particularly for those undergoing cardiopulmonary functional testing or for monitoring conditions like HCM and heart failure transition care. PMcardio is broadly applicable for interpreting 12-lead ECGs for over 50 cardiac conditions, serving emergency physicians, cardiologists, GPs, nurses, and paramedics in acute care, screening, and monitoring.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring prolaio eVO2peak Module or PMcardio

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.